When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 32 Hits
  • Search Condition : Filter (MeSH = Lung Neoplasms / drug therapy)
Species Resource
Human and Animal Cells B16/BL6(RCB2638) Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
Human and Animal Cells HLC-1(RCB0083) Ghrelin does not influence cancer progression in a lung adenocarcinoma cell line.
Human and Animal Cells MRC-5(RCB0211) Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.
Human and Animal Cells LM8(RCB1450) The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma.
Human and Animal Cells A431(RCB0202), A549(RCB0098), 293(RCB1637) Delivery of a Proapoptotic Peptide to EGFR-Positive Cancer Cells by a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR.
Human and Animal Cells LC-1/sq(RCB0455) , RERF-LC-AI(RCB0444) , HLC-1(RCB0083) , RERF-LC-KJ(RCB1313) Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.
Human and Animal Cells Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
Human and Animal Cells Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation.
Human and Animal Cells Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells.
Human and Animal Cells SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer.
Human and Animal Cells MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.
Human and Animal Cells WEHI-3B(RCB2853) A secondary RET mutation in the activation loop conferring resistance to vandetanib.
Human and Animal Cells Lu-165(RCB1184) MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.
Human and Animal Cells LC-2/ad(RCB0440) EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells.
Human and Animal Cells Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors.
Human and Animal Cells Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Human and Animal Cells Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activities.
Human and Animal Cells Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad.
Human and Animal Cells PC-14 (RCB0446) Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line.
Human and Animal Cells Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras.